# A Study in Subjects With Advanced Solid Tumors

> **NCT04156100** · PHASE1 · TERMINATED · sponsor: **Agenus Inc.** · enrollment: 19 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** AGEN1223
- **DRUG:** AGEN1223 and balstilimab

## Key facts

- **NCT ID:** NCT04156100
- **Lead sponsor:** Agenus Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-10
- **Primary completion:** 2021-04-08
- **Final completion:** 2021-09-29
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Strategic business decision.
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04156100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04156100, "A Study in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04156100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*